SCHEMBL7040046

SCHEMBL7040046

COc1ccc(C(CN)C(=O)Nc2ccccc2)cc1OC

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 4/20 0.55
MEN1 O00255 4/20 0.55
KMT2A Q03164 4/20 0.55
MAPT P10636 3/20 0.55
ROCK2 O75116 4/20 0.53
KCNQ2 O43526 1/20 0.51
ALDH1A1 P00352 4/20 0.48
NPSR1 Q6W5P4 2/20 0.48
TDP1 Q9NUW8 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
ROCK1 Q13464 2/20 0.47
MYLK4 Q86YV6 2/20 0.47
NPC1 O15118 1/20 0.47
STAT1 P42224 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CRHBP P24387 1/20 0.47
CRHR2 Q13324 1/20 0.47
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7040630 0.82 F2 (0.54) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL7040833 0.81 NPC1 (0.58) MAPTALDH1A1NPC1RAB9ASMN1; SMN2
SCHEMBL7038489 0.81 ACHE (0.59) KMT2AALDH1A1NPSR1L3MBTL1ACHE
SCHEMBL28196332 0.80 ACHE (0.49) LMNAKCNQ2ALDH1A1TDP1L3MBTL1
SCHEMBL11001026 0.79 ALDH1A1 (0.52) LMNAKCNQ2ALDH1A1SMN1; SMN2HPGD
SCHEMBL11312500 0.74 LDHA (0.56) LMNAMEN1KMT2AMAPTROCK2
SCHEMBL5743088 0.74 CA12 (0.52) LMNAMEN1KMT2AMAPTALDH1A1
SCHEMBL7040224 0.74 ACHE (0.48) KCNQ2ALDH1A1ACHE
SCHEMBL22593372 0.74 LMNA (0.53) LMNAMEN1KMT2AMAPTROCK2
Hydrochloric Acid SCHEMBL5743084 0.73 CA12 (0.51) LMNAMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0659737-B1 Catecholamine surrogates useful as beta 3 agonists BRISTOL MYERS SQUIBB CO (US) 2003-03-26 EP disclosed
US-5776983-A ANTIDIABETIC AGENTS, OBESITY, GASTROINTESTINAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1998-07-07 US disclosed
EP-0659737-A2 Catecholamine surrogates useful as B3 agonists BRISTOL-MYERS SQUIBB COMPANY (US) 1995-06-28 EP disclosed